Stents Global Market Report 2025

The stents market size has grown strongly in recent years. It will grow from $11.26 billion in 2024 to $11.92 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth during the historical period can be attributed to the rising prevalence of cardiovascular diseases, an aging population, greater awareness of minimally invasive procedures, increased healthcare spending, a higher adoption rate of drug-eluting stents, and a growing number of angioplasty procedures.

The stents market size is expected to see strong growth in the next few years. It will grow to $14.86 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth during the forecast period is expected to result from increased government healthcare initiatives, a rising prevalence of diabetes, a growing population of high-risk patients, a higher demand for customized stents, and increased collaboration between medical device manufacturers and hospitals. Key trends in the forecast period include advancements in stent design technology, the expansion of healthcare infrastructure in emerging markets, the development of 3D-printed stents, miniaturized stents for smaller arteries, and the use of robotic-assisted stent deployment.

The increasing prevalence of cardiovascular disorders is expected to drive the growth of the stents market in the future. Cardiovascular disorders are health conditions that affect the heart or blood vessels, impairing the heart's function. The rise in these disorders is linked to factors such as physical inactivity, which can lead to obesity, high blood pressure, and poor cardiovascular health by reducing the efficiency of the heart and circulation. Stent placement helps by restoring blood flow in narrowed or blocked arteries, thus reducing the risk of heart attacks and other complications. For example, in January 2025, the British Heart Foundation reported that 7.6 million people in the UK were living with heart and circulatory diseases, accounting for nearly 27% of all deaths in the country, resulting in over 170,000 fatalities annually. As a result, the growing prevalence of cardiovascular disorders is fueling the growth of the stent market.

Companies in the stent market are focusing on developing innovative technologies, such as drug-eluting stents, to improve efficacy, reduce restenosis rates, and enhance patient outcomes. Drug-eluting stents are small mesh tubes placed in arteries that slowly release medication to prevent the artery from narrowing again after treatment. For instance, in August 2022, Medtronic launched the Onyx Frontier, its next-generation drug-eluting coronary stent system, after receiving CE Mark approval. This advanced stent builds on the Resolute Onyx platform and features design improvements such as an innovative dual-layer balloon, a lower crossing profile, and greater catheter flexibility. These upgrades lead to a 16% improvement in deliverability compared to the previous generation, without sacrificing radial strength. The Onyx Frontier is designed to support extra-large vessels, with sizes ranging from 2.0mm to 5.0mm and expandable up to 6.00mm.

In January 2024, Olympus Corporation, a Japanese manufacturer of optics and reprography products, acquired Taewoong Medical Co. Ltd. for $370 million. With this acquisition, Olympus aims to strengthen its position in the gastrointestinal market by expanding its portfolio of innovative therapeutic stents and enhancing its presence in the global medical device industry. Taewoong Medical specializes in manufacturing gastrointestinal metallic stents and will help Olympus provide comprehensive solutions for gastrointestinal disorders.

Major players in the stents market are Abbott Laboratories, Medtronic plc, Becton, Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Terumo Corporation, Teleflex Incorporated, Cook Group Inc., Biotronik SE & Co. KG, Merit Medical Systems Inc., Micro-Tech Europe, Meril Life Sciences, MicroPort Scientific Corporation, Biosensors International Group Ltd., Novatech SA, Elixir Medical Corporation, Vascular Concepts Ltd., and Veryan Medical Limited.

North America was the largest region in the stents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in stents report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A stent is a small, mesh-like device that is inserted into a narrowed or blocked blood vessel to help maintain its openness and ensure proper blood circulation. It is commonly used in medical procedures to treat conditions such as coronary artery disease and to prevent arteries from collapsing after balloon angioplasty.

The primary types of stents include coronary stents, peripheral stents, stent-related implants, biliary stents, carotid stents, and neurovascular stents. Coronary stents are tiny mesh tubes inserted into the arteries of the heart to keep them open when they become blocked or narrowed due to plaque buildup. These stents are made from various materials, including metallic, polymer, and natural biomaterials, and are used by a range of end users such as hospitals, clinics, ambulatory surgical centers, and others.

The stents market research report is one of a series of new reports that provides stents market statistics, including stents industry global market size, regional shares, competitors with a stents market share, detailed stents market segments, market trends and opportunities, and any further data you may need to thrive in the stents industry. The stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The stents market consists of sales of products such as renal artery stents, ureteral stents, and gastrointestinal stents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.